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GM1-gangliosidosis is an inherited autosomal recessive disorder
caused by mutations in the gene GLB1, which encodes acid β-
galactosidase (β-gal). The lack of activity in this lysosomal enzyme
leads to accumulation of GM1 gangliosides (GM1) in cells. We have
developed a high-content-imaging method to assess GM1 levels in
ﬁbroblasts that can be used to evaluate substrate reduction in
treated GLB1/ cells [1]. This assay allows ﬂuorescent quantiﬁ-
cation in a multi-well system which generates unbiased and sta-
tistically signiﬁcant data. Fluorescently labeled Cholera Toxin B
subunit (CTXB), which speciﬁcally binds to GM1 gangliosides, was
used to detect in situ GM1 levels in a ﬁxed monolayer of ﬁbro-
blasts. This sensitive, rapid, and inexpensive method facilitates
in vitro drug screening in a format that allows a high number of
replicates using low working volumes.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.ymgme.2015.12.002
W. Acosta).
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Dubject area Biology.
ore speciﬁc sub-
ject areaInborn errors of metabolism.ype of data Fluorescence microscopy images, tables, ﬁgures.
ow data was
acquiredBD Pathway 855 High Content Bioimager (BD Biosciences).ata format Raw, segmented, analyzed.
xperimental
factorsAfter attachment in a black wall, clear bottom 96 well plate, normal (GLB1þ /þ)
and GM1-gangliosidosis (GLB1/) ﬁbroblasts were incubated untreated or
treated with recombinant β-gal for 24 h.xperimental
featuresAfter treatment, cells were ﬁxed, permeabilized and stained with ﬂuores-
cently labeled CTXB.
Nuclei were counter stained with DAPI to allow cell count.
Individual images were acquired in each well using both ﬁlters.
Images were segmented using Attovision software.
Segmentation data were analyzed using BD Data Explorers.
CTXB pixels per cell were calculated in each image-well.
Treatment values were expressed as average pixel/cell.ata source
locationImages collected in Jonesboro, Arkansas, USA.ata accessibility Data is with this article.D
Value of the data We describe an imaging method that statistically differentiates levels of GM1 gangliosides in
mammalian cells [1].
 These data describe a sensitive, rapid, and unbiased high-throughput imaging method that allows
quantiﬁcation of GM1 gangliosides in situ.
 This method can be easily used in primary compound screening or for the testing of post-primary
treatment conditions, due to advantages of the low required level of sample processing and
treatment volumes.
 This assay can be adapted to multiple high-content-imaging instruments [2].1. Data
High-content screening allows quantiﬁcation of data obtained by ﬂuorescence imaging in a multi-
well format. Using this technology, we were able to statistically differentiate substrate levels
(po0.0001) between normal (GLB1þ /þ) and enzyme deﬁcient (GLB1 /) human ﬁbroblasts.
Reduction of substrate levels can be detected when GM1-gangliosidosis ﬁbroblast (GLB1/) are
treated with a corrective recombinant protein.2. Experimental design, materials and methods
2.1. Conjugation of Dylight 594 to CTXB
For GM1 ganglioside detection, Dylight 594 (Thermo Cat 46412) was conjugated to the primary
amines of Cholera Toxin B protein (CTXB) (List Biologicals Cat 104) following manufacture's protocol.
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macrophages and ﬁbroblasts) using ﬂuorescent microscopy [3,4].
2.2. Cell treatment
Suspended Normal (GLB1þ /þ; Coriell GM-00010) and GM1-gangliosidosis (GLB1 /; Coriell GM-
10919) ﬁbroblasts were diluted to 100,000 cells/ml and plated to a black-walled, clear bottom 96-well
microtiter plates using 100 ml/well. Following a 24 h attachment period, media was replaced with
100 ml serum-free media (untreated) or serum-free media containing 6 nM of recombinant β-gal
(R&D Systems). Cells were incubated for 24 h at 37 °C and 5% CO2. These parameters had been
optimized to provide cell densities (impacted by cell type, cell line, growth rate, and treatment
incubation times) with enough separation for accurate capture of cell count and resolution of the
region of interest (ROI).
2.3. Fluorescence staining of cells
Cells were ﬁxed with 4% paraformaldehyde for 8 min followed by 3X washes with PBS. Cells were
permeabilized for 10 min using 0.25% Triton X-100 solution and blocked with 1% BSAþ0.3 M glycine
in PBS for 1 h.
Cells were incubated with conjugated CTXB-Dylight594 at 1:1600 dilution in PBS for 1 h at room
temperature. Wells were washed 3X with PBS and cells were maintained in a PBS solution containing
600 nM DAPI and 0.03% sodium azide. Optimization of permeabilization time, Triton X-100 con-
centration, and CTXB-Dylight594 dilution was made in order to avoid signal saturation and improve
assay sensitivity.
2.4. Image acquisition
Images were acquired with the BD Pathway 855 High Content Bioimager (BD Biosciences). A
20X NA 075 objective was used to acquire 22 montage images per well using DAPITable 1
Acquisition parameters.
1.1. DAPI 1.2. Texas Red
Auto dynamic range On Auto dynamic range On
Dynamic range min 800 Dynamic range min 350
Dynamic range max 3200 Dynamic range max 1500
Gain 0 Gain 0
Offset 255 Offset 255
Exposure 0.3 Exposure 0.2
Lamp intensity 100 Lamp intensity 100
Excitation position A 380/10 Excitation position B 560/55
Dichroic excitation position 3 open Dichroic excitation position Mirror
Dichroic epiﬂuorescence
position
400DCLP Dichroic epiﬂuorescence
position
595LP
Emission position A 435LP Emission position A 645/75
Confocal No Confocal No
Background subtraction Off Background subtraction Off
Table 2
Segmentation parameters for nuclei and GM1 aggregates deﬁnition.
2.1. Nuclei segmentation 2.2. GM1 aggregates segmentation
Threshold mode: Automatic Threshold mode: Manual
Number of threshold
steps
1 Min threshold: 294
Level 1 offset mode Percent Max threshold: 4095
Level 1 offset percent 0.000000 Scrap min pixels: 10
Scrap min pixels: 500 Scrap max pixels: 50,000
Scrap max pixels: No maximum Scrap mode: Normal
Scrap mode: Normal Shape: Polygon
Shape: Polygon Dilation: 0
Dilation: 0 ROI output: Whole cell
ROI output: Nucleus Watershed: Off
Watershed: Off Preprocessing
ﬁlters:
On
Preprocessing ﬁlters: On
Filter2 (A) Erode 33 Filter4 (A): Top hat
(77)
Filter3 (A) Sharpen hat
Filter4 (A) RB 7575
Fig. 1. Nuclei segmentation process. After deﬁning dye signal threshold, every image was segmented using the same para-
meters described in Table 2.1. Nuclei segmentation was used for cell counting.
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Fig. 2. GM1 aggregates segmentation process. After deﬁning dye signal threshold and applying ﬁlters, every image was seg-
mented using the same parameters described in Table 2.2. Pixel area of each aggregate was used to calculate total pixels
per image.
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acquired per each image yielded an average of 150 cells per image. All images were acquired
using the same parameters summarized in Table 1 using the instrument's automated laser
autofocus (Fig. 3).2.5. Image segmentation
Images were segmented using Attovision software. Nuclei were counted in DAPI images by using
polygon segmentation parameters described in Table 2.1. GM1 aggregates within cells were deﬁned in
Texas Red images using polygon segmentation parameters described in Table 2.2. All images were
segmented using the same segmentation parameters deﬁned for each ﬁlter channel. The segmenta-
tion process is depicted in Figs. 1 and 2.2.6. Data analysis
Data analysis was performed using BD Data Explorers software (BD Biosciences). Total pixels,
corresponding to GM1 gangliosides, were calculated by adding the area of one of each GM1
aggregate polygons in each image/repetition. Total pixels were divided by number of cells
(nucleus count) in the corresponding image. Data were expressed as the average of CTXB-
Dylight594 pixels per cell ratios in each treatment. Twelve images (n¼12) per treatment were
used to determine the average value (Table 3). Considering that each image included an average
150 cells at this magniﬁcation, the total amount of cells analyzed for each treatment was
approximately 1800.
Table 3
Segmentation quantitative data in untreated normal ﬁbroblast, GM1-gangliosidosis ﬁbroblast and GM1-gangliosidosis ﬁbroblast treated with 6 nM of recombinant human β-galactosidase
for 24 h.
Untreated GLB1þ /þ ﬁbroblasts Untreated GLB1 / ﬁbroblasts GLB1 / ﬁbroblastsþ6 nM β-gal
Well
ID
GM1 aggregates
count
Total GM1
pixels
Cell
count
Pixels/
cell
Well
ID
GM1 aggregates
count
Total GM1
pixels
Cell
count
Pixels/
cell
Well
ID
GM1 aggregates
count
Total GM1
pixels
Cell
count
Pixels/
cell
A001 5 115 50 2 A003 570 10,652 94 113 A005 131 2997 99 30
A002 18 383 201 2 A004 1195 24,797 110 225 A006 649 12,237 120 102
B001 4 114 54 2 B003 2544 45,589 168 271 B005 277 5456 147 37
B002 62 975 161 6 B004 2053 43,573 124 351 B006 613 11,481 178 65
C001 6 129 84 2 C003 782 14,401 119 121 C005 117 2856 158 18
C002 48 840 122 7 C004 1616 30,804 150 205 C006 315 5520 150 37
D001 1 19 21 1 D003 1031 19,449 151 129 D005 291 6819 142 48
D002 9 197 140 1 D004 3687 67,779 186 364 D006 378 6944 193 36
E001 6 95 131 1 E003 1138 20,604 129 160 E005 386 7300 158 46
E002 26 457 115 4 E004 3746 75,338 155 486 E006 578 10,198 159 64
F001 68 1125 143 8 F003 1299 25,129 133 189 F005 421 7850 177 44
F002 16 217 119 2 F004 3356 63,919 217 295 F006 415 6854 170 40
Ave 22 389 112 3 Ave 1918 36,836 145 243 Ave 381 7209 154 47
StDev 24 382 51 2 StDev 1146 22,092 34 115 StDev 171 2952 26 22
StErr 6 102 14 1 StErr 306 5904 9 31 StErr 46 789 7 6
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Fig. 3. CTXB signal in different treatments. Image thumbnails of data acquired using Texas Red ﬁlter. Substrate accumulation
differences are evident among treatments.
W. Acosta et al. / Data in Brief 6 (2016) 1016–10221022Acknowledgments
This research was supported by funding to BioStrategies LC from an NIH/NINDS Phase I SBIR grant
(1R43NS084565-01). The BD pathway was purchased through a NSF MRI grant (DBI-0960089) to
C.L.C, Arkansas State University.References
[1] J. Condori, W. Acosta, J. Ayala, V. Katta, A. Flory, R. Martin, et al., Enzyme replacement for GM1-gangliosidosis: uptake,
lysosomal activation, and cellular disease correction using a novel β-galactosidase: RTB lectin fusion, Mol. Genet. Metab.
(2016), in press.
[2] F. Zanella, J.B. Lorens, W. Link, High content screening: seeing is believing, Trends Biotechnol. 28 (5) (2010) 237–245,
Elsevier Ltd.
[3] C. Beer, L. Pedersen, M. Wirth, Amphotropic murine leukaemia virus envelope protein is associated with cholesterol-rich
microdomains, Virol J. 2 (2005) 36.
[4] K.A. Powers, K. Szaszi, R.G. Khadaroo, P.S. Tawadros, J.C. Marshall, A. Kapus, et al., Oxidative stress generated by hemor-
rhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages, J. Exp. Med. 203 (8) (2006) 1951–1961.
